DONATE-Pilot Study on ICU Management of Deceased Organ Donors

Status Completed

Clinical Trial Summary

The DONATE-Pilot is a prospective observational cohort study in organ donation (OD) that observes the ICU management of consented deceased organ donors at 4 high volume centres over a period of 12 months each. The pilot study will be followed by a 1-year prospective national observational study a 15-20 ICUs across Canada.

Clinical Trial Description

This prospective observational cohort pilot study enrols consented organ donors admitted to 4 high volume centres over a period of 12 months. Various clinical data on deceased donors are collected prospectively from the time of consent for organ donation up to and including the day of organ recovery.

The main objectives of the DONATE-Pilot reflect the objectives of the national study which correspond to the steps in developing a platform for future clinical trials.

1. Form research teams at participating ICUs that will include an ICU physician-researcher, a local organ donation champion, ICU research coordinators and (in a limited role) a local coordinator from the provincial Organ Donation Organization (ODO);

2. Observe, record, and describe ICU practices in deceased donor care (e.g., donor resuscitation, organ suitability assessments, death declaration) which are likely to vary by site, region and province and will be very important to inform clinical care protocols for future RCTs.

3. Engage and work with ODOs from each province to foster data sharing and develop procedures to enhance efficiency in future RCTs.

4. Investigate the comparative effectiveness of various ICU interventions in deceased donor care (e.g. the potential for hormonal therapies to improve transplant rates, the potential of heparin therapy to improve peri-operative graft function);

5. Produce specific knowledge translation tools that will serve in the future as both clinical tools to enhance ICU care and research tools to facilitate future RCTs.

As part of the DONATE-Pilot we also aim to assess feasibility. Specifically the objectives are to:

1. Refine data collection procedures for deceased donors in ICU;

2. Estimate time requirements for data collection;

3. Develop efficient links to post-transplantation data and;

4. Share data as it accrues with clinicians. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02902783
Study type	Observational [Patient Registry]
Source	McMaster University
Contact
Status	Completed
Phase
Start date	September 2015
Completion date	March 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05114551` - ICU Predictive Score of WEaning Success in Patients At Risk of Extubation Failure
Completed	`NCT05547646` - The Prevalence of Healthcare-associated Infection in Medical Intensive Care Units in Tunisia
Recruiting	`NCT03697785` - Weaning Algorithm for Mechanical VEntilation	N/A
Completed	`NCT02922101` - Evaluation of the Effectiveness of an Audit and Feedback Intervention With Quality Improvement Toolbox in Intensive Care	N/A
Completed	`NCT01857986` - Evaluating Air Leak Detection in Intubated Patients	N/A
Completed	`NCT01885442` - TryCYCLE: A Pilot Study of Early In-bed Leg Cycle Ergometry in Mechanically Ventilated Patients	N/A
Recruiting	`NCT05518955` - VR Integrated Into Multicomponent Interventions for Improving Sleep in ICU	N/A
Recruiting	`NCT03810768` - Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
Completed	`NCT03295630` - Validity of an Actigraph Accelerometer Following Critical Illness	N/A
Completed	`NCT05556811` - HEaling LIght Algorithms for the ICU Patient	N/A
Recruiting	`NCT05702411` - Air Stacking Technique For Pulmonary Reexpansion	N/A
Completed	`NCT02741453` - Bilateral Internal Jugular Veins Ultrasound Scanning Prior to CVC Placement	N/A
Recruiting	`NCT04979897` - Impact on Mental, Physical, And Cognitive Functioning of a Critical Care sTay During the COVID-19 Pandemic
Completed	`NCT05281224` - Ventilator Tube Holder for Patients With a Tracheostomy
Withdrawn	`NCT02970903` - VitalPAD: an Intelligent Monitoring and Communication Device to Optimize Safety in the PICU	N/A
Recruiting	`NCT02587273` - The Pharmacokinetics of Fentanyl in Intensive Care Patients	Phase 4
Completed	`NCT02661607` - Point of Care Echocardiography Versus Chest Radiography for the Assessment of Central Venous Catheter Placement	N/A
Completed	`NCT01479153` - Venous Site for Central Catheterization	N/A
Recruiting	`NCT06110390` - High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients	N/A
Not yet recruiting	`NCT05593380` - The Effect of BIA Monitoring of Brain Edema on the Neurological Prognosis of Supratentorial Massive ICH	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

DONATE-Pilot Study on ICU Management of Deceased Organ Donors — DONATE-Pilot

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms